Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -10.15
- Piotroski Score 3.00
- Grade Buy
- Symbol (HUMA)
- Company Humacyte, Inc.
- Price $4.44
- Changes Percentage (-8.17%)
- Change -$0.4
- Day Low $4.26
- Day High $4.84
- Year High $9.97
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; and coronary artery bypass grafting, as well as developing its HAVs for pediatric heart surgery and cellular therapy delivery, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/20/2025
- Fiscal Year End N/A
- Average Stock Price Target $6.00
- High Stock Price Target $10.00
- Low Stock Price Target $5.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.00
- Trailing P/E Ratio -7.27
- Forward P/E Ratio -7.27
- P/E Growth -7.27
- Net Income $-110,776,000
Income Statement
Quarterly
Annual
Latest News of HUMA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Day One Ventures & Masha Bucher: Big Ideas For Humanity
Masha Bucher, founder of Day One Ventures, aims to bridge the gap between technology and society by supporting tech entrepreneurs and connecting them with artists. Through investments in companies lik...
By Forbes | 1 day ago -
Evolving Together: Human-AI Coevolution Is Said To Be Coming Whether Humanity Likes It Or Not
The discussion on human-AI coevolution is gaining momentum, with opinions divided. Some argue that AI and humans are evolving together, while others dismiss it as unfounded. The impact of AI on human ...
By Forbes | 1 day ago -
A New Study Suggests Humans Prefer AI Over Human Written Poems -- Do You?
A recent study in Nature Scientific Reports found that people struggle to differentiate between poetry written by humans and AI. Participants favored AI poems for their clarity and themes, raising que...
By Forbes | 1 day ago
